WHO ICTRP trial
COBRA treat-to-target trial
NL-OMON19866 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON19866 |
|---|---|
| Public title | COBRA treat-to-target trial |
| Scientific title | COBRA treat-to-target trial |
| Primary sponsor | VU University Medical Center |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Patients with early rheumatoid arthritis |
| Interventions | This is a multicenter study containing a randomisation step after incomplete response at 13 weeks and with two strategy arms: one arm of patients with unfavourable prognostic factors, the so-called ‘high risk group’ (group 1), and in the… |
| Registration date | Apr 2, 2014 |
| Target size | 190 |
| Secondary IDs | NL4393;NTR4524;NL45991.029.13 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: